Evidence map›Paper›PMID 29138607›Full record

ArticlePsychology research and behavior management2017

Evaluation of sleep profile in schizophrenia patients treated with extended-release paliperidone: an open-label prospective study in Southeast Asia.

Ronnachai Kongsakon, Nuntika Thavichachart, Ka Fai Chung, Leslie Lim, Beverly Azucena, Elizabeth Rondain, Benson Go, Fe Costales, Osot Nerapusee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Psychology research and behavior management, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ronnachai KongsakonDepartment of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Nuntika ThavichachartDepartment of Medicine, Division of Psychiatry, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
Ka Fai ChungDepartment of Psychiatry, University of Hong Kong, Hong Kong, People's Republic of China.
Leslie LimDepartment of Psychiatry, Singapore General Hospital, Singapore.
Beverly AzucenaNational Center for Mental Health, Mandaluyong, Philippines.
Elizabeth RondainMakati Medical Center, Makati, Philippines.
Benson GoNorthern Mindanao Medical Center, Cagayan De Oro, Misamis Oriental, Philippines.
Fe CostalesPerpetual Succour Hospital, Cebu, Philippines.
Osot NerapuseeMedical Affairs, Janssen-Cilag, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effect of 6 months of treatment with paliperidone extended-release (ER) tablets on the sleep profile of patients with schizophrenia.

methodsA total of 984 patients meeting the

resultsApproximately 70% of patients completed the 6-month study. After the use of paliperidone ER, patients reported significantly better sleep quality (76.44 vs 65.48;

conclusionPaliperidone ER can help schizophrenia patients to improve sleep quality and reduce daytime drowsiness; this was seen especially in the patients who completed the 6-month treatment period and had higher baseline Positive and Negative Syndrome Scale scores.

Indexed as

CGI-Spaliperidone ERPANSSschizophreniasleep profile

Identifiers

PMID29138607
PMCPMC5667782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.